Stock listing

Hamburg:7PO Poxel SA Aktie

German listing (Hamburg) of Poxel SA · home listing Euronext:POXEL

Follow Poxel SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:POXEL

€0.126 EUR -0.017 (-11.9%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:POXEL

Past year -48.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€0.126 – €0.140 EURNov 20, 2026
Volume
1.24M sharesNov 20, 2026
Market cap
€8.45M EURAt the close on Nov 20, 2026 · price × 66.96M shares outstanding
52-week range
€0.126 – €0.480 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€122,440 EURMedian day 342,301 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Poxel SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:POXEL · Home€0.126 EUR-0.017 (-11.9%)1,242,193€0.140€0.140€0.126€0.143Close on Nov 20, 2026
Frankfurt:7PO€0.131 EUR-0.006 (-4.4%)—€0.131€0.131€0.131€0.137Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:POXEL · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.126-0.017-11.9%€0.140€0.140€0.1261,242,193
€0.143-0.002-1.6%€0.150€0.150€0.143201,252
€0.146-0.003-2.0%€0.149€0.149€0.144178,824
€0.149+0.003+1.9%€0.146€0.153€0.146836,701
€0.146-0.004-2.8%€0.154€0.154€0.145414,963
€0.150-0.003-2.0%€0.153€0.154€0.150229,277
€0.1530.0000.0%€0.153€0.156€0.153210,539
€0.153-0.003-2.0%€0.156€0.156€0.150190,707
€0.156+0.004+2.8%€0.152€0.157€0.152273,768
€0.152-0.004-2.6%€0.156€0.156€0.148726,195
€0.156-0.002-1.3%€0.159€0.160€0.156176,856
€0.158+0.004+2.6%€0.154€0.161€0.152308,863
€0.154-0.006-3.8%€0.160€0.163€0.152438,787
€0.160-0.005-3.1%€0.166€0.174€0.158868,119
€0.165-0.006-3.6%€0.172€0.172€0.163345,436
€0.171+0.010+6.5%€0.161€0.178€0.158849,849
€0.161-0.002-1.0%€0.163€0.163€0.158565,070
€0.163-0.004-2.4%€0.167€0.169€0.160436,853
€0.167-0.007-3.9%€0.173€0.173€0.162498,929
€0.173-0.013-7.0%€0.186€0.186€0.173544,304
€0.186-0.011-5.4%€0.197€0.197€0.184419,071
€0.197+0.014+7.4%€0.191€0.209€0.1831,727,432
€0.183-0.040-17.8%€0.223€0.243€0.1803,848,782
€0.223+0.075+50.7%€0.151€0.270€0.1517,667,004
€0.148-0.008-5.1%€0.156€0.156€0.147855,115
€0.156-0.015-9.0%€0.171€0.171€0.154331,947
€0.171+0.021+13.8%€0.151€0.184€0.1511,645,713
€0.151+0.016+11.6%€0.135€0.185€0.1352,646,280
€0.135+0.001+0.7%€0.135€0.136€0.134341,110
€0.134+0.000+0.1%€0.134€0.136€0.133343,492
€0.134-0.001-0.7%€0.135€0.136€0.134141,807
€0.135+0.000+0.3%€0.134€0.135€0.133176,790
€0.134-0.003-2.2%€0.135€0.137€0.132466,679
€0.137-0.013-8.4%€0.150€0.150€0.130986,393
€0.150-0.016-9.9%€0.167€0.167€0.150786,453
€0.166-0.004-2.1%€0.170€0.170€0.166105,194
€0.1700.000-0.1%€0.170€0.170€0.16798,523
€0.170-0.005-2.7%€0.175€0.175€0.170216,202
€0.175-0.001-0.8%€0.177€0.177€0.175139,529
€0.176+0.002+1.4%€0.174€0.178€0.173211,959
€0.174-0.004-2.2%€0.178€0.180€0.174269,633
€0.178-0.018-9.0%€0.195€0.196€0.178582,321
€0.196+0.014+7.8%€0.182€0.208€0.1811,818,659
€0.181+0.018+11.3%€0.163€0.194€0.163920,369
€0.163+0.001+0.9%€0.162€0.163€0.161136,146
€0.162-0.006-3.8%€0.167€0.168€0.158361,596
€0.168-0.010-5.6%€0.178€0.178€0.166336,659
€0.178+0.000+0.1%€0.178€0.178€0.17693,706
€0.178-0.003-1.4%€0.180€0.180€0.176260,035
€0.180-0.005-2.5%€0.185€0.185€0.180195,779
€0.185+0.001+0.8%€0.184€0.186€0.184201,202
€0.184-0.004-1.9%€0.187€0.188€0.183175,114
€0.187-0.005-2.4%€0.190€0.192€0.186240,624
€0.192-0.001-0.4%€0.193€0.193€0.190113,727
€0.193-0.004-2.1%€0.197€0.197€0.182372,280
€0.1970.000-0.1%€0.199€0.199€0.195204,501
€0.197-0.001-0.4%€0.200€0.200€0.195425,154
€0.198-0.003-1.6%€0.202€0.202€0.197188,538
€0.2010.0000.0%€0.195€0.203€0.195442,611
€0.201-0.001-0.2%€0.202€0.204€0.200265,811
€0.202-0.005-2.7%€0.205€0.210€0.202214,820
€0.207-0.007-3.3%€0.211€0.211€0.203439,543
€0.214-0.022-9.3%€0.237€0.250€0.2131,529,547
€0.236+0.041+20.9%€0.195€0.237€0.1951,769,063
€0.195-0.001-0.5%€0.196€0.196€0.19568,360
€0.196-0.003-1.3%€0.200€0.200€0.196106,641
Ticker
Hamburg:7PO
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Hamburg
Currency
EUR

What changed lately

Latest news

All Poxel SA news

Poxel SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 34 in all · newest Nov 9, 2026 · oldest 2025
Decks
13 decks · latest Oct 16, 2025

Where Poxel SA is listed

ListingExchangeCountryCurrency
Euronext:POXEL · Home listingEuronextFranceEUR
LSIN:0RA2LSINUnited KingdomEUR
Lang & Schwarz:A14M04Lang & SchwarzGermanyEUR
LS Exchange:A14M04LS ExchangeGermanyEUR
Frankfurt:7POFrankfurtGermanyEUR
OTC:PXXLFOTCUnited StatesUSD
Aquis:POXELPAquisUnited KingdomEUR
Aquis:POXELPAquisUnited KingdomEUR
Dusseldorf:7PODusseldorfGermanyEUR
gettex:7POgettexGermanyEUR
Hamburg:7PO · This pageHamburgGermanyEUR
Munich:7POMunichGermanyEUR
Stuttgart:7POStuttgartGermanyEUR
Turquoise:POXELPTurquoiseUnited KingdomEUR

Valuation

balance Jun 30, 2025 · price Nov 20, 2026

Enterprise value
€67.38M EUR
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Poxel SA · EURONEXT:POXELUS$9.27MUS$73.95Mn/an/an/an/an/an/an/a
Purple Biotech Ltd. · TASE:PPBTUS$9.70MUS$3.73Mn/an/an/a0.8×n/a0.0×n/a
Jasper Therapeutics, Inc. · NASDAQ:JSPRUS$9.64M−US$125.6Mn/a−15.7×n/an/an/an/a2.02
Alzinova AB · OMXSTO:ALZUS$9.58MUS$8.35Mn/a17.0×n/a0.6×−484.4%0.0×n/a
Chemomab Therapeutics Ltd. · NASDAQ:CMMBUS$9.58MUS$4.92Mn/an/an/a2.6×n/a0.0×1.04
Genvor Incorporated · OTC:GNVRUS$9.47MUS$9.27Mn/an/an/an/an/an/a0.44
TScan Therapeutics, Inc. · NASDAQ:TCRXUS$9.27M−US$30.80Mn/a−5.9×n/a0.2×n/a0.9×1.66
Rapid Dose Therapeutics Corp · CSE:DOSEUS$9.13MUS$9.12Mn/a5.1×n/an/a−123.1%n/a0.64
CytoMed Therapeutics Limited · NASDAQ:GDTCUS$9.01MUS$8.23Mn/a14.7×n/a2.3×−730.3%0.1×0.16
PreveCeutical Medical Inc · CSE:PREVUS$8.97MUS$8.95Mn/an/an/an/an/an/a0.73
BioLineRX Ltd. · TASE:BLRXUS$8.90MUS$10.13Mn/a8.6×n/a0.5×−171.7%0.3×n/a
Median of the othersUS$9.37MUS$8.29M6.8×0.7×−328.0%0.1×0.73

Team and board

Officers

OfficerRole
Yves DecadtChief Executive Officer
Antoine de BoissieuChief Financial Officer
Alexandre MassiasInvestor Relations / Media
Aurélie ManavarereInvestor Relations / Media
Paul BoivinInvestor relations / Media
Théo MartinInvestor relations / Media
Thomas CozzolinoInvestor relations / Media

Board

DirectorRole
Laure-Hélène MercierChair of the Board of Directors
Amit KohliIndependent Director
Yves DecadtChief Executive Officer

Events

QuarterResultsShare move
Quarter to Dec 31, 2025Mar 25, 2026+2.7%
Quarter to Sep 30, 2025Nov 7, 2025+10.5%
Q2 2025Sep 23, 2025+1.3%
Quarter to Mar 31, 2025Apr 22, 2025+14.0%
Quarter to Sep 30, 2024Oct 3, 2024+12.3%
Quarter to Mar 31, 2024May 16, 2024−4.9%
Q4 2023Feb 15, 2024 · After close−0.4%
Quarter to Sep 30, 2023Nov 8, 2023 · After close−0.3%
Q2 2023Aug 30, 2023 · After close−4.8%
Q1 2023May 3, 2023 · After close−0.3%
All 19 quarters
QuarterResultsShare move
Q4 2022Mar 23, 2023 · Before open−3.3%
Q3 2022Oct 4, 2022 · After close−5.8%
Q2 2022Aug 8, 2022 · After close+13.0%
Q1 2022May 17, 2022 · After close+2.9%
Q4 2021Mar 23, 2022−19.1%
Q3 2021Oct 20, 2021 · After close−0.7%
Q2 2021Jul 21, 2021 · After close+1.3%
Q1 2021Apr 21, 2021 · After close0.0%
Q4 2020Mar 24, 2021 · After close−0.3%

Open Events

Decks

DeckKindSlidesDate
FY2024 Earnings PresentationEarnings17 slidesOct 16, 2025
Investor Presentation (December 2024)Investor deck36 slidesDecember 2024
FY2023 Earnings PresentationEarnings27 slidesOct 3, 2024
H1 2023 Earnings PresentationEarnings33 slidesSep 26, 2023
FY2022 Earnings PresentationEarnings38 slidesMar 23, 2023
H1 2022 Earnings PresentationEarnings43 slidesSep 21, 2022
FY2021 Earnings PresentationEarnings27 slidesMar 22, 2022
H1 2021 Earnings PresentationEarnings30 slidesSep 23, 2021
Investor Presentation (July 2021)Investor deck33 slidesJul 12, 2021
FY2020 Earnings PresentationEarnings42 slidesMar 25, 2021
All 13 decks
DeckKindSlidesDate
Technical Presentation (October 2020)Technical19 slidesOct 1, 2020
H1 2020 Earnings PresentationEarnings28 slidesSep 15, 2020
Technical Presentation (September 2016)Technical13 slidesSep 14, 2016

Open Decks

Financings

RaiseDateIn US dollars
Rights offering of new shares (capital increase with preemptive subscription rights)
Update: rights offering
Buyers: IPF (guarantees the capital increase, subject to not exceeding 29.9% of the Company's share capital following the transaction); IPF Invest Co 2 S.à.r.l. (guarantees the capital increase with preemptive subscription rights)
Apr 30, 2026
At-the-market programme of warrants to subscribe new ordinary shares (SmartATM equity line)
Update: at-the-market programme
Buyers: IRIS (Subscribed 40 million warrants; financing commitment of up to €5 million over five years in twenty €250,000 quarterly tranches)
Insiders: The equity line does not create any conflict of interest for directors or corporate officers
Use of proceeds: Secure the financial foundation needed to implement the company's recovery plan; part of the restructuring of IRIS bond debt
Feb 3, 2026
Bonds (IPF bond loan)
Tranche closed: €500,000 raised
Buyers: IPF Partners (bond issue for a maximum amount of €2.5 million under an additional Tranche D of the IPF bond loan); IPF (new bond borrowings of €3.75 million, in addition to €2.5 million of bonds issued during the observation period)
Use of proceeds: Fund Poxel's financing needs under the recovery plan until it generates positive cash flow
Jan 30, 2026US$586,560

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in EUR

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue6.64M1.98M674.0K13.4M6.81M26.6M74.6M5.29M70.3K59.6K
Cost of revenue2.94M1.98M672.0K59.0K000025.2K
Gross profit3.69M1.00K2.00K13.3M6.81M26.6M74.6M5.29M70.3K34.5K
Research and development1.00M21.0M13.9M27.5M29.2M44.5M58.1M24.1M20.9M9.24M
Selling, general and administrative5.03M4.44M10.6M9.94M7.41M4.49M3.45M3.83M2.68M
Operating income-3.50M-28.8M-21.9M-22.5M-29.8M-24.7M12.5M-21.9M-24.3M-11.7M
Depreciation and amortization17.2M555.0K556.0K551.0K424.0K62.0K37.9K32.0K23.0K
EBITDA-11.6M-21.3M-21.9M-29.3M-24.2M12.6M-21.9M-24.3M-11.7M
Interest expense14.0M6.15M9.91M2.95M1.73M233.0K28.0K46.5K572.4K918.8K
Income before tax-18.3M-35.1M-31.4M-23.8M-31.8M-25.7M13.6M-22.3M-24.5M-12.2M
Income tax2.00K2.00K2.00K2.00K36.0K1.00K77.0K395.9K200.6K-124.2K
Net income-18.3M-35.1M-31.4M-23.8M-31.8M-25.7M13.5M-22.7M-24.5M-12.2M
Earnings per share, basic-0.38-1.05-1.08-0.83-1.16-0.990.54-0.99-1.16-0.68
Earnings per share, diluted-0.38-1.05-1.08-0.83-1.16

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents3.66M2.34M13.1M32.3M40.2M37.2M66.7M54.2M45.6M42.4M
Short-term investments-86.0K-193.0K3.53M24.6M19.0M59.4M50.0M-184.3K
Receivables4.62M385.0K394.0K50.0K281.0K14.8M15.6M11.5M3.88M2.54M
Inventory-1.56M01898.0K1552.3K617226
Current assets14.9M4.52M16.6M36.3M46.0M52.9M88.3M66.3M49.6M46.2M
Property, plant and equipment121.0K1.32M1.72M2.22M2.32M296.0K143.0K145.4K152.7K
Total assets14.9M4.82M34.7M54.9M65.1M72.3M105.5M66.8M50.3M46.8M
Accounts payable2.05M3.30M4.41M8.42M8.36M10.2M8.65M3.25M4.92M2.82M
Current liabilities19.0M13.3M27.4M15.9M16.5M30.8M49.1M46.6M10.1M7.14M
Long-term debt40.1M24.5M29.0M19.5M62.0K359.0K555.0K708.6K1.55M
Total debt47.0M43.4M35.1M23.6M7.70M14.2M1.31M1.58M3.15M
Total liabilities53.9M53.0M46.7M38.2M33.2M49.7M47.4M10.9M8.82M
Shareholders' equity-58.9M-49.1M-18.2M8.21M27.1M39.1M55.8M19.3M39.4M38.0M
Shares outstanding38.6M29.1M28.6M27.5M25.9M24.8M23.0M21.1M17.9M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-9.51M-14.0M-21.8M-16.9M-25.7M-25.7M-4.74M8.13M-18.8M-10.1M
Capital spending-17.0M-11.0K-28.0K-235.0K-113.0K-7.88M-35.8K-24.6K-143.9K
Free cash flow3.05M-21.8M-16.9M-26.0M-25.8M-12.6M8.09M-18.9M-10.2M
Cash from investing92.0K41.0K0-42.0K52.0K352.0K-7.61M213.1K179.8K96.9K
Cash from financing10.7M3.23M2.58M9.03M28.7M-4.21M25.7M-496.0K21.8M42.1M
Dividends paid-250.0K
Share buybacks0295.0K16.9M1.03M12.2M546.0K26.8M-250.0K
Change in cash1.31M-10.7M-19.2M-7.92M3.02M-29.6M13.3M7.84M3.16M32.2M

Open Financials

Cap table

Built by 6ix from Poxel SA’s releases · as of Sep 29, 2025

Common shares
66,959,377
Fully diluted
66,959,377

Fully diluted

LineShares
Common shares66,959,377

Share count over time

CountShares
Nov 22, 202666,959,377

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alexandre MassiasInvestor Relations / Media · Since at least Sep 3, 2026
Amit KohliIndependent Director · Since at least Aug 1, 2025
Antoine de BoissieuChief Financial Officer · Since at least Nov 5, 2026
Arthur RouilléInvestor relations / Media · Dec 10, 2025 – Nov 5, 2026 · Past
Aurélie ManavarereInvestor Relations / Media · Since at least Nov 20, 2025
Laure-Hélène MercierChair of the Board of Directors · Since at least Sep 3, 2026
Paul BoivinInvestor relations / Media · Since at least Feb 16, 2026
Théo MartinInvestor relations / Media · Since at least Jun 10, 2026
Thomas CozzolinoInvestor relations / Media · Since at least Apr 30, 2026
Yves DecadtChief Executive Officer · Since Jun 10, 2026

Open People

Log in to ask 6ix AI your own questions about Poxel SA.